CI
BIO icon

CX Institutional’s Bio-Rad Laboratories Class A BIO Stock Holding History

CX Institutional’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7
Closed -$3K – 526
2022
Q2 		$3K Buy
+7
New +$3.65K ﹤0.01% 1059
2021
Q4 		– Sell
-15
Closed -$11K – 393
2021
Q3 		$11K Hold
15
– – ﹤0.01% 816
2021
Q2 		$10K Hold
15
– – ﹤0.01% 831
2021
Q1 		$9K Buy
15
+1
+7% +$592 ﹤0.01% 772
2020
Q4 		$8K Buy
14
+11
+367% +$6.26K ﹤0.01% 747
2020
Q3 		$2K Hold
3
– – ﹤0.01% 799
2020
Q2 		$1K Buy
+3
New +$1.32K ﹤0.01% 785

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CX Institutional's BIO Position: Q3 2022 in Review

CX Institutional sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 7 shares — an estimated $3K sold.

CX Institutional first reported a position in BIO in Q2 2020 and held it in 7 quarters. The position peaked at $11K in Q3 2021. 484 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

  • CX Institutional reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
  • CX Institutional sold 7 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $3K.
  • CX Institutional first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 7 quarters.
  • CX Institutional's Bio-Rad Laboratories Class A position peaked at $11K in Q3 2021.
  • 484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on CX Institutional's 13F filing for Q3 2022, filed 4 Nov 2022.